Akums Drugs to hold 22nd AGM on July 10, 2026; proposes ₹3/share dividend

Akums Drugs and Pharmaceuticals Ltd announced its 22nd Annual General Meeting (AGM) to be held on Friday, July 10, 2026, at 11:00 A.M. (IST) via video conferencing. The agenda includes adopting audited standalone and consolidated financial statements for FY26. The Board has recommended a final dividend of Re. 1/- and a special dividend of Rs. 2/-, totaling Rs. 3/- per equity share (@150%) for FY26, with a record date of July 03, 2026. Other key items include the re-appointment of Mr. Sanjay Sinha as a Director and the ratification of the Cost Auditors' remuneration for FY26-27 at Rs. 3,00,000/- plus taxes. The meeting will also consider revising the remuneration of Mr. Sanjeev Jain, Managing Director.